Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Cancer Med. 2023 Jun;12(11):12198-12207. doi: 10.1002/cam4.5914. Epub 2023 Apr 16.
Fine-needle aspiration cytology (FNAC) represents an important diagnostic tool for the workup of salivary gland (SG) lesions. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is a six-tiered system for standardizing diagnoses and improvement of communication between pathologists and clinicians, providing risk of malignancy (ROM) rates for every category. The aims of the present study were (i) to validate the use of MSRSGC in a large series of SG FNAC in a tertiary center in Switzerland, (ii) to determine ROM for each category and compare them with data from MSRSGC and similar studies, and (iii) to investigate whether there were relevant differences of non-diagnostic results between fine-needle aspirations (FNA) performed by cytopathologists compared to non-cytopathologists.
The files of the department of Pathology in the University Hospital Zurich (UHZ) were searched for SG FNAC between 2010 and 2019. The MSRSGC guidelines were applied retrospectively. Furthermore, ROM, risk of neoplasia (RON), sensitivity, and specificity were calculated based on the cases with histopathological follow-up.
A total of 2156 SG FNAC including 753 cases with histopathological follow-up were evaluated. Generally, ROM was within the range of values provided by MSRSGC, with some minor deviations. Sensitivity was 94.6%, and specificity was 99.3%.
Our study confirms the usefulness of MSRSGC. In addition, it provides a detailed insight into the wide spectrum of SG FNAC. Finally, we showed that the rate of non-diagnostic FNA was significantly lower in FNAs performed by cytopathologists compared to non-cytopathologists.
细针吸取细胞学(FNAC)是唾液腺(SG)病变检查的重要诊断工具。米兰唾液腺细胞病理学报告系统(MSRSGC)是一个用于标准化诊断和改善病理学家与临床医生之间沟通的六级系统,为每个类别提供恶性肿瘤风险(ROM)率。本研究的目的是:(i)在瑞士的一个三级中心的大量 SG FNAC 系列中验证 MSRSGC 的使用;(ii)确定每个类别的 ROM,并将其与 MSRSGC 和类似研究的数据进行比较;(iii)研究在由细胞病理学家与非细胞病理学家进行的细针抽吸(FNA)之间,非诊断结果是否存在相关差异。
在苏黎世大学医院(UHZ)病理科的档案中搜索 2010 年至 2019 年期间的 SG FNAC。回顾性应用 MSRSGC 指南。此外,根据具有组织病理学随访的病例计算 ROM、肿瘤风险(RON)、敏感性和特异性。
共评估了 2156 例 SG FNAC,其中 753 例有组织病理学随访。总体而言,ROM 在 MSRSGC 提供的范围内,存在一些较小的偏差。敏感性为 94.6%,特异性为 99.3%。
我们的研究证实了 MSRSGC 的有用性。此外,它提供了对广泛的 SG FNAC 的详细了解。最后,我们表明,与非细胞病理学家相比,由细胞病理学家进行的 FNA 的非诊断性 FNA 率明显更低。